Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Sever, Yildiz, G; Resch, E; Strenger, V; Eber, E; Resch, B.
Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)].
Influenza Other Respir Viruses. 2024; 18(11): e70046
Doi: 10.1111/irv.70046
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Sever Yildiz Gülsen
- Co-authors Med Uni Graz
-
Eber Ernst
-
Resch Bernhard
-
Resch-Poteralski Elisabeth
-
Strenger Volker
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVE: RSV bronchiolitis is a leading cause of hospitalization in infants and young children. We aimed to document the economic burden and epidemiology of RSV over seven seasons in Southern Austria. PATIENTS AND METHODS: All RSV-associated hospitalized (PCR-proven) children ≤ 5 years of age between 1 October 2015 and 30 April 2022 were collected retrospectively. Demographic and epidemiologic data, along with hospitalization costs (direct and indirect), were calculated. RESULTS: Among 976 children hospitalized due to RSV infection, 87% were healthy term infants, and 79% were < 12 months old. Prematurity (13%) and pre-existing conditions (11%) significantly impacted older children-59% of cases in the 2nd compared with 68% in the 1st year of live. RSV-related hospital costs were approximately €2.0 millions per year (of a total of 60 millions per year). RSV accounted for 19% of hospitalizations due to acute respiratory illness (ARI) in children ≤ 5 years, 37% of all ARI < 6 months, 28% of all ARI < 12 and 6.3% of all-cause hospitalizations < 12 months of age, respectively. CONCLUSIONS: Every 5th hospitalization due to respiratory illness in children ≤ 5 years of age was associated with RSV, representing 7.9% of all hospitalizations and 3.3% of all paediatric hospitalization costs.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
Respiratory Syncytial Virus Infections - epidemiology, economics
-
Austria - epidemiology
-
Infant - administration & dosage
-
Hospitalization - economics, statistics & numerical data
-
Male - administration & dosage
-
Female - administration & dosage
-
Child, Preschool - administration & dosage
-
Retrospective Studies - administration & dosage
-
Infant, Newborn - administration & dosage
-
Respiratory Syncytial Virus, Human - isolation & purification
-
Cost of Illness - administration & dosage
-
Seasons - administration & dosage
- Find related publications in this database (Keywords)
-
bronchiolitis
-
economic burden of disease
-
epidemiology
-
hospitalization cost
-
preterm infant
-
respiratory syncytial virus